Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

QUIZARTINIB for Leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where QUIZARTINIB was used for Leukaemia.

Most Reported Side Effects for QUIZARTINIB

Side Effect Reports % Deaths Hosp.
Off label use 47 13.2% 2 3
No adverse event 40 11.2% 0 0
Death 32 9.0% 32 5
Platelet count decreased 27 7.6% 5 12
Nausea 25 7.0% 2 8
Disease progression 20 5.6% 8 6
Pyrexia 20 5.6% 1 15
Electrocardiogram qt prolonged 19 5.3% 3 4
Febrile neutropenia 19 5.3% 4 12
Product dose omission issue 18 5.0% 1 7
Infection 17 4.8% 4 11
Pneumonia 16 4.5% 5 11
Fatigue 14 3.9% 0 5
Therapy change 13 3.6% 1 3
Asthenia 12 3.4% 0 7

Other Indications for QUIZARTINIB

Acute myeloid leukaemia (274) Product used for unknown indication (37) Acute leukaemia (15) Acute myeloid leukaemia (in remission) (5) Acute myelomonocytic leukaemia (5)

Other Drugs Used for Leukaemia

DASATINIB (654) VENETOCLAX (307) CYTARABINE (288) METHOTREXATE (282) IMATINIB (281) RUXOLITINIB (230) NILOTINIB (203) BOSUTINIB (191) VINCRISTINE (172) CYCLOPHOSPHAMIDE (153)

Related Pages

QUIZARTINIB Full Profile All Leukaemia Drugs QUIZARTINIB Demographics QUIZARTINIB Timeline